메뉴 건너뛰기




Volumn 117, Issue 3, 2011, Pages 650-656

Variable risk of cervical precancer and cancer after a human papillomavirus-positive test

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; CYTOLOGY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; PRECANCER; PRIORITY JOURNAL; RISK ASSESSMENT; SERODIAGNOSIS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

EID: 79952024069     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e318209da59     Document Type: Article
Times cited : (11)

References (21)
  • 1
    • 34648851164 scopus 로고    scopus 로고
    • 2006 Consensus guidelines for the management of women with abnormal cervical screening tests
    • DOI 10.1097/LGT.0b013e3181585870, PII 0012836020071000000001
    • Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D; 2006 ASCCP-Sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis 2007;11:201-22. (Pubitemid 47530909)
    • (2007) Journal of Lower Genital Tract Disease , vol.11 , Issue.4 , pp. 201-222
    • Wright Jr., T.C.1    Massad, L.S.2    Dunton, C.J.3    Spitzer, M.4    Wilkinson, E.J.5    Solomon, D.6
  • 2
    • 1442305204 scopus 로고    scopus 로고
    • Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening
    • Wright TC Jr, Schiffman M, Solomon D, Cox JT, Garcia F, Goldie S, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004;103:304-9.
    • (2004) Obstet Gynecol , vol.103 , pp. 304-309
    • Wright Jr., T.C.1    Schiffman, M.2    Solomon, D.3    Cox, J.T.4    Garcia, F.5    Goldie, S.6
  • 3
    • 54549104813 scopus 로고    scopus 로고
    • Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: Joint European cohort study
    • Oct 13; doi:10.1136/bmj.a1754
    • Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 2008 Oct 13;337:a1754. doi:10.1136/bmj.a1754.
    • (2008) BMJ , vol.337
    • Dillner, J.1    Rebolj, M.2    Birembaut, P.3    Petry, K.U.4    Szarewski, A.5    Munk, C.6
  • 4
    • 77649187281 scopus 로고    scopus 로고
    • Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: A randomised controlled trial
    • Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010;11:249-57.
    • (2010) Lancet Oncol , vol.11 , pp. 249-257
    • Ronco, G.1    Giorgi-Rossi, P.2    Carozzi, F.3    Confortini, M.4    Dalla Palma, P.5    Del Mistro, A.6
  • 5
    • 33751164570 scopus 로고    scopus 로고
    • The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period
    • DOI 10.1158/0008-5472.CAN-06-1057
    • Kjaer S, Hogdall E, Frederiksen K, Munk C, van den Brule A, Svare E, et al. The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period. Cancer Res 2006;66:10630-6. (Pubitemid 44799787)
    • (2006) Cancer Research , vol.66 , Issue.21 , pp. 10630-10636
    • Kjaer, S.1    Hogdall, E.2    Frederiksen, K.3    Munk, C.4    Van, D.B.A.5    Svare, E.6    Meijer, C.7    Lorincz, A.8    Iftner, T.9
  • 6
    • 69449084161 scopus 로고    scopus 로고
    • Short term persistence of human papillomavirus and risk of cervical precancer and cancer: Population based cohort study
    • Jul 28; doi: 10.1136/bmj.b2569
    • Castle PE, Rodriguez AC, Burk RD, Herrero R, Wacholder S, Alfaro M, et al. Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. BMJ 2009 Jul 28;339:b2569. doi: 10.1136/bmj.b2569.
    • (2009) BMJ , vol.339
    • Castle, P.E.1    Rodriguez, A.C.2    Burk, R.D.3    Herrero, R.4    Wacholder, S.5    Alfaro, M.6
  • 7
    • 77749279734 scopus 로고    scopus 로고
    • Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: Critical role of duration of infection
    • Rodriguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, et al. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst 2010;102:315-24.
    • (2010) J Natl Cancer Inst , vol.102 , pp. 315-324
    • Rodriguez, A.C.1    Schiffman, M.2    Herrero, R.3    Hildesheim, A.4    Bratti, C.5    Sherman, M.E.6
  • 8
    • 34249025057 scopus 로고    scopus 로고
    • The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: An ALTS report
    • Castle PE, Stoler MH, Solomon D, Schiffman M. The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report. Am J Clin Pathol 2007;127:805-15.
    • (2007) Am J Clin Pathol , vol.127 , pp. 805-815
    • Castle, P.E.1    Stoler, M.H.2    Solomon, D.3    Schiffman, M.4
  • 9
    • 34548497655 scopus 로고    scopus 로고
    • Human papillomavirus and cervical cancer
    • DOI 10.1016/S0140-6736(07)61416-0, PII S0140673607614160
    • Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007;370:890-907. (Pubitemid 47371147)
    • (2007) Lancet , vol.370 , Issue.9590 , pp. 890-907
    • Schiffman, M.1    Castle, P.E.2    Jeronimo, J.3    Rodriguez, A.C.4    Wacholder, S.5
  • 12
    • 60749099876 scopus 로고    scopus 로고
    • Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2
    • Castle PE, Schiffman M, Wheeler CM, Solomon D. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol 2009;113:18-25.
    • (2009) Obstet Gynecol , vol.113 , pp. 18-25
    • Castle, P.E.1    Schiffman, M.2    Wheeler, C.M.3    Solomon, D.4
  • 13
    • 79551491522 scopus 로고    scopus 로고
    • The accuracy of colposcopic biopsy: Analyses from the placebo arm of the Gardasil clinical trials
    • May 20 Epub ahead of print
    • Stoler MH, Vichnin MD, Ferenczy A, Ferris DG, Perez G, Paavonen J, et al. The accuracy of colposcopic biopsy: analyses from the placebo arm of the Gardasil clinical trials. Int J Cancer 2010 May 20 [Epub ahead of print].
    • (2010) Int J Cancer
    • Stoler, M.H.1    Vichnin, M.D.2    Ferenczy, A.3    Ferris, D.G.4    Perez, G.5    Paavonen, J.6
  • 14
    • 67649382952 scopus 로고    scopus 로고
    • HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): A randomised controlled trial
    • Kitchener HC, Almonte M, Thomson C, Wheeler P, Sargent A, Stoykova B, et al. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol 2009;10:672-82.
    • (2009) Lancet Oncol , vol.10 , pp. 672-682
    • Kitchener, H.C.1    Almonte, M.2    Thomson, C.3    Wheeler, P.4    Sargent, A.5    Stoykova, B.6
  • 15
    • 69149095476 scopus 로고    scopus 로고
    • Further analysis of the ARTISTIC trial
    • Sasieni P, Castle PE, Cuzick J. Further analysis of the ARTISTIC trial. Lancet Oncol 2009;10:841-2.
    • (2009) Lancet Oncol , vol.10 , pp. 841-842
    • Sasieni, P.1    Castle, P.E.2    Cuzick, J.3
  • 16
    • 23244438005 scopus 로고    scopus 로고
    • The elevated 10-Year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice
    • DOI 10.1093/jnci/dji187
    • Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005;20:97:1072-9. (Pubitemid 41417924)
    • (2005) Journal of the National Cancer Institute , vol.97 , Issue.14 , pp. 1072-1079
    • Khan, M.J.1    Castle, P.E.2    Lorincz, A.T.3    Wacholder, S.4    Sherman, M.S.5    Scott, D.R.6    Rush, B.R.7    Glass, A.G.8    Schiffman, M.9
  • 17
    • 52749088718 scopus 로고    scopus 로고
    • Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: A nested substudy of the NTCC randomised controlled trial
    • Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, De Marco L, et al. Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial. Lancet Oncol 2008;9:937-45.
    • (2008) Lancet Oncol , vol.9 , pp. 937-945
    • Carozzi, F.1    Confortini, M.2    Dalla Palma, P.3    Del Mistro, A.4    Gillio-Tos, A.5    De Marco, L.6
  • 18
    • 70449338341 scopus 로고    scopus 로고
    • A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions
    • Phila
    • Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, et al. A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prev Res (Phila) 2009;2:868-78.
    • (2009) Cancer Prev Res , vol.2 , pp. 868-878
    • Kjaer, S.K.1    Sigurdsson, K.2    Iversen, O.E.3    Hernandez-Avila, M.4    Wheeler, C.M.5    Perez, G.6
  • 19
    • 34948815559 scopus 로고    scopus 로고
    • 2006 Consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ
    • DOI 10.1097/LGT.0b013e318159408b, PII 0012836020071000000002
    • Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D; 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. J Low Genit Tract Dis 2007;11:223-39. (Pubitemid 47530910)
    • (2007) Journal of Lower Genital Tract Disease , vol.11 , Issue.4 , pp. 223-239
    • Wright Jr., T.C.1    Massad, L.S.2    Dunton, C.J.3    Spitzer, M.4    Wilkinson, E.J.5    Solomon, D.6
  • 21
    • 71249085643 scopus 로고    scopus 로고
    • Risk estimation for the next generation of prevention programmes for cervical cancer
    • Katki HA, Wacholder S, Solomon D, Castle PE, Schiffman M. Risk estimation for the next generation of prevention programmes for cervical cancer. Lancet Oncol 2009;10:1022-3.
    • (2009) Lancet Oncol , vol.10 , pp. 1022-1023
    • Katki, H.A.1    Wacholder, S.2    Solomon, D.3    Castle, P.E.4    Schiffman, M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.